Minimize Uncertainty – Make Informed Decisions – Succeed

Respiratory

Respiratory Weekly News—September 12th, 2025

September 12, 2025Phage Pa223,Tozorakimab,astrazeneca,UMBRIEL trial,BioPharma and Tech News,NS Pharma,vapendavir,Nippon Shinyaku,EGPA,NS-229,Pulmovant,Altesa BioSciences,Mosliciguat,bioMérieux,PH-ILD,BIOFIRE SPOTF,Aptar Pharma,Respiratory News,Dianosic,ARIS scaffold,NHS England,Childhood AsthmaArmata Pharmaceuticals,AP-PA02

This Week in Respiratory Health: Orphan Drugs, Asthma Campaigns, Phage Science,…

by LucidQuest

Cardiovascular

Cardiovascular Weekly News - September 11th 2025

September 11, 2025Thrombectomy,Chagas,cardiology,HLHS,clinical trials,Cardiac MRI,BioPharma and Tech News,LGE,HEART FAILURE,Dilated Cardiomyopathy,medtech,PFA,PCSK9,Cardiovascular News,HFpEF,stem cell therapy,Atrial fibrillation,stroke,ESC 2025,HFrEFOSA,CPAP

Cardiovascular Update: Verquvo Miss, CPAP Rethink, nsPFA IDE and More This…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - September 11th 2025

September 11, 2025Kite Gilead,DMD Cardiomyopathy,Yescarta,Cell and Gene Therapy News,BioPharma and Tech News,DLBCL,NSCLC,Eli Lilly,Fabry,Remedium Bio,Nanoscope Therapeutics,Stargardt,XLRP,Ultragenyx,GSDIaLyell Immunopharma,CD19/CD20

Gene & Cell Therapy Update: Lilly Obesity Deal, RMAT for Stargardt, XLRP…

by LucidQuest

Rare Disease news

Rare Diseases Weekly News - September 11th 2025

September 11, 2025Rare Disease News,biotechpharma,drug development,FDA,BioPharma and Tech News,#RareDiseases #FragileX #GM2 #BehcetsDisease #PDCD #ALGS #PFIC Bylvay,Odevixibat,RDEP,Orphan Drug Designation,Access,Specialty Pharmacy,ICIEM,Fabry,Alpha Mannosidosis

🧬 This Week in Rare Diseases: Servier Fragile X deal, FDA RDEP, Bylvay Canada…

by LucidQuest

Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - September 11th 2025

September 11, 2025Oxford University,Ellison Institute,digital health,Eight Sleep,telehealth,Corsera Health,AI in healthcare,Remedy Meds,BioPharma and Tech News,Thirty Madison,Novo Nordisk,Laennec AI,NeuroTech,Microsoft,cardiovascular health,NHS,medical technology,Sleep Technology,BCI,Causal AI,China,RNA interference,Kakao Healthcare,Health Technology,Brain Computer Interface,AI Vaccines,NeurotechnologyAI in Healthcare and Digital Health,LG CNS

AI & Digital Health Update – Sep 11, 2025: China BCI plan, £118M AI vax,…

by Timos Papagatsias

Neuroscience

Neuroscience Weekly News - September 10th 2025

September 10, 2025biosimilars,multiple sclerosis,BioPharma and Tech News,PTSD,Silo Pharma,Hope Biosciences,Regenerative Medicine Advanced Therapy (RMAT),Polpharma Biologics,MS Pharma,Pabinafusp AlfaMPS II,Neuroscience News

🧠 This Week in Neuroscience: PTSD Treatment, MS Stem Cell Therapy and More…

by LucidQuest

Immunology

Immunology Weekly News - September 10th 2025

September 10, 2025Fibrostenotic Crohn’s Disease,SIK3 Inhibitor,BioPharma and Tech News,Tigulixostat,neffy,Zoryve,Crohns Disease,Immunology News,Anaphylaxis,hidradenitis suppurativa,Febuxostat,Palisade Bio,MRM Health,Microbiome-based therapeutics,Boomerang Medical,Neuromodulation,Pediatric plaque psoriasisOnco3R Therapeutics,Inmedix

🔬 This week in Immunology Updates: Gout Treatment, Crohn's Disease Mapping and…

by LucidQuest

Obesity Weekly News

Obesity Weekly News - September 9th 2025

September 9, 2025semaglutide,BioPharma and Tech News,Tirzepatide,Orforglipron,Qsymia,AmetrisDECODE Obesity,Obesity News

Obesity Updates: WHO EML GLP-1s, Orforglipron P3, Korea MOU and More…

by LucidQuest

Endocrinology

Endocrinology Weekly Update - September 9th 2025

September 9, 2025BioPharma and Tech News,naperigliprondenosumab biosimilars,ADCES25,insulin-requiring T2D,Armour Thyroid,levothyroxine,Endocrinology News

🧬 Endocrinology Update: New denosumab versions, Tzield in China and More…

by LucidQuest

Onco_background

Oncology Weekly News - September 8th 2025

September 8, 2025VEGF pathway,Oncology News,BioPharma and Tech News,lung cancer,NSCLC,antibody drug conjugate,KRAS G12C,EGFR-mutated NSCLC,HER2-mutant NSCLC,Companion diagnostic,Bispecific antibody,EGFR inhibitor,EGFR-MET antibody,PD-1 inhibitorPD-L1 inhibitor,PD-1/VEGF bispecific

🔬🧬 Oncology Updates: Tagrisso survival boost, J&J combo win and More…

by LucidQuest

Hematology

Hematology Weekly News - September 8th 2025

September 8, 2025Cilta-cel,Lyell,janssen,IDA.,Carvykti,Hematology News,BioPharma and Tech News,AML,DLBCL,MM,LBCL,MZL,Thalassemia,CellCentric,Inobrodib,p300/CBP InhibitorLegend,Ciltacabtagene Autoleucel

🔬🩸 Hematology Updates: Functional Cure Signals, Head-to-Head CAR-T, Outpatient…

by LucidQuest

IASLC 2025_Preview_by_LucidQuest

IASLC 2025 Preview: Key Lung Cancer Highlights to Watch

September 6, 2025Our Insights,immunotherapylung cancer,Small Cell Lung Cancer,Non-small cell lung cancer,liquid biopsy,Conference Previews,ai in oncology,screening,WCLC 2025,IASLC,perioperative therapy,SABR

IASLC 2025 at a glance With IASLC 2025 on the horizon, LucidQuest's…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.